Free Trial
LON:MXCT

MaxCyte (MXCT) Share Price, News & Analysis

MaxCyte logo
GBX 193 -2.00 (-1.03%)
As of 04/17/2025 11:50 AM Eastern

About MaxCyte Stock (LON:MXCT)

Key Stats

Today's Range
190.60
197.60
50-Day Range
183
330
52-Week Range
177
410
Volume
29,878 shs
Average Volume
45,474 shs
Market Capitalization
£254.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions. Let’s Build Better Cells Together. To learn more, please visit www.maxcyte.com

Receive MXCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MaxCyte and its competitors with MarketBeat's FREE daily newsletter.

MXCT Stock News Headlines

MaxCyte to Propose AIM Delisting to Shareholders
MaxCyte (MXCT) Gets a Buy from BTIG
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
MaxCyte management to meet with BTIG
MaxCyte price target lowered to $9 from $11 at Stifel
See More Headlines

MXCT Stock Analysis - Frequently Asked Questions

MaxCyte's stock was trading at GBX 321.20 at the start of the year. Since then, MXCT stock has decreased by 39.9% and is now trading at GBX 193.
View the best growth stocks for 2025 here
.

Shares of MXCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MaxCyte investors own include HSBC (HSBA), Royal Dutch Shell (RDSB), Cassava Sciences (SAVA), EQTEC (EQT), Grafton Group (GFTU), Lloyds Banking Group (LLOY) and Marks and Spencer Group (MKS).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Business Services
Current Symbol
LON:MXCT
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-45,081,271.80
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£57.52 million
Cash Flow
GBX 97.87 per share
Price / Cash Flow
1.97
Book Value
GBX 203.85 per share
Price / Book
0.95

Miscellaneous

Free Float
N/A
Market Cap
£254.77 million
Optionable
Not Optionable
Beta
1.13
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (LON:MXCT) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners